Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events
Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events
Recruiting · NCT06640010 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events | Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm | Recruiting | Not stated | 2026-06-23 | NCT06640010 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic in Florida | Jacksonville | United States | 224 |